Tessa Schillemans

About me
Publications
CV
Public outreach and news

About me

I am a postdoctoral researcher in the unit of Cardiovascular and Nutritional
Epidemiology at the Institute of Environmental Medicine (IMM). My background
is molecular biology and molecular mechanisms of disease, which I studied in
the Netherlands. My current research is a continuation of my PhD research and
investigates the impact of a group of environmental pollutants, called
perfluoroalkyl substances (PFAS), on cardiovascular disease. Within my
research we include multi-omics datasets such as genetics, proteins and
metabolomics to gain insight in potential underlying mechanisms that link
PFAS exposures to cardiometabolic disturbances.

Articles

Article: ENVIRONMENT INTERNATIONAL. 2024;187:108727
Per- and polyfluoroalkyl substances (PFAS) and fetal growth: A nation-wide register-based study on PFAS in drinking water
Save-Soderbergh M; Gyllenhammar I; Schillemans T; Lindfeldt E; Vogs C; Donat-Vargas C; Ankarberg EH; Glynn A; Ahrens L; Helte E; Akesson A
Article: ENVIRONMENTAL SCIENCE AND TECHNOLOGY. 2024;58(2):1036-1047
OMICs Signatures Linking Persistent Organic Pollutants to Cardiovascular Disease in the Swedish Mammography Cohort
Schillemans T; Yan Y; Ribbenstedt A; Donat-Vargas C; Lindh CH; Kiviranta H; Rantakokko P; Wolk A; Landberg R; Akesson A; Brunius C
Article: BIOINFORMATICS ADVANCES. 2024;4(1):vbae051
Adjusting for covariates and assessing modeling fitness in machine learning using MUVR2
Yan Y; Schillemans T; Skantze V; Brunius C
Article: ENVIRONMENTAL POLLUTION. 2023;335:122214
PFAS association with kisspeptin and sex hormones in teenagers of the HBM4EU aligned studies
Rodriguez-Carrillo A; Remy S; Koppen G; Wauters N; Freire C; Olivas-Martinez A; Schillemans T; Akesson A; Desalegn A; Iszatt N; den Hond E; Verheyen V; Fabelova L; Murinova LP; Pedraza-Diaz S; Castana A; Garcia-Lario JV; Cox B; Govarts E; Baken K; Tena-Sempere M; Olea N; Schoeters G; Fernandez MF
Article: JAMA NETWORK OPEN. 2023;6(9):e2333347
Blood Levels of Organochlorine Contaminants Mixtures and Cardiovascular Disease
Donat-Vargas C; Schillemans T; Kiviranta H; Rantakokko P; de Faire U; Arrebola JP; Wolk A; Leander K; Akesson A
Article: TOXICS. 2023;11(8):711
PFAS and Phthalate/DINCH Exposure in Association with Age at Menarche in Teenagers of the HBM4EU Aligned Studies
Cox B; Wauters N; Rodriguez-Carrillo A; Portengen L; Gerofke A; Kolossa-Gehring M; Lignell S; Lindroos AK; Fabelova L; Murinova LP; Desalegn A; Iszatt N; Schillemans T; Akesson A; Colles A; Den Hond E; Koppen G; Van Larebeke N; Schoeters G; Govarts E; Remy S
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2023;201(4):783-792
Plasma protein and venous thromboembolism: prospective cohort and mendelian randomisation analyses
Yuan S; Titova OE; Zhang K; Gou W; Schillemans T; Natarajan P; Chen J; Li X; Akesson A; Bruzelius M; Klarin D; Damrauer SM; Larsson SC
Article: ENVIRONMENTAL POLLUTION. 2023;316(Pt 1):120566
Cross-sectional associations between exposure to per- and polyfluoroalkyl substances and body mass index among European teenagers in the HBM4EU aligned studies
Schillemans T; Iszatt N; Remy S; Schoeters G; Fernandez MF; D'Cruz SC; Desalegn A; Haug LS; Lignell S; Lindroos AK; Fabelova L; Murinova LP; Kosjek T; Tkalec Z; Gabriel C; Sarigiannis D; Pedraza-Diaz S; Esteban-Lopez M; Castano A; Rambaud L; Riou M; Pauwels S; Vanlarebeke N; Kolossa-Gehring M; Vogel N; Uhl M; Govarts E; Akesson A
Article: ENVIRONMENTAL RESEARCH. 2023;216(Pt 2):114570
Associations of PFAS-related plasma metabolites with cholesterol and triglyceride concentrations
Schillemans T; Bergdahl IA; Hanhineva K; Shi L; Donat-Vargas C; Koponen J; Kiviranta H; Landberg R; akesson A; Brunius C
Article: ENVIRONMENTAL HEALTH PERSPECTIVES. 2022;130(3):37007
Per- and Polyfluoroalkyl Substances and Risk of Myocardial Infarction and Stroke: A Nested Case-Control Study in Sweden
Schillemans T; Donat-Vargas C; Lindh CH; de Faire U; Wolk A; Leander K; Akesson A
Article: FRONTIERS IN PHYSIOLOGY. 2022;13:909870
Associations of Polymorphisms in the Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Gene With Subsequent Coronary Heart Disease: An Individual-Level Meta-Analysis
Schillemans T; Tragante V; Maitusong B; Gigante B; Cresci S; Laguzzi F; Vikstrom M; Richards M; Pilbrow A; Cameron V; Foco L; Doughty RN; Kuukasjarvi P; Allayee H; Hartiala JA; Tang WHW; Lyytikainen L-P; Nikus K; Laurikka JO; Srinivasan S; Mordi IR; Trompet S; Kraaijeveld A; van Setten J; Gijsberts CM; Maitland-van der Zee AH; Saely CH; Gong Y; Johnson JA; Cooper-DeHoff RM; Pepine CJ; Casu G; Leiherer A; Drexel H; Horne BD; van der Laan SW; Marziliano N; Hazen SL; Sinisalo J; Kahonen M; Lehtimaki T; Lang CC; Burkhardt R; Scholz M; Jukema JW; Eriksson N; Akerblom A; James S; Held C; Hagstrom E; Spertus JA; Algra A; de Faire U; Akesson A; Asselbergs FW; Patel RS; Leander K
Journal article: ISEE CONFERENCE ABSTRACTS. 2021;2021(1)
Chlorinated persistent organic pollutants in plasma and risk of cardiovascular disease: a prospective nested case-control study in two Swedish cohorts
Donat Vargas C; Donat Vargas C; Donat Vargas C; Schillemans T; Kiviranta H; De Faire UU; Wolk A; Arrebola P; Arrebola P; Leander K; Åkesson A
Journal article: ISEE CONFERENCE ABSTRACTS. 2021;2021(1)
Perfluoroalkyl substances and risk of myocardial infarction and stroke
Schillemans T; Donat Vargas C; Lindh CH; De Faire U; Wolk A; Leander K; Åkesson A
Article: ENVIRONMENT INTERNATIONAL. 2021;146:106180
Plasma metabolites associated with exposure to perfluoroalkyl substances and risk of type 2 diabetes - A nested case-control study
Schillemans T; Shi L; Donat-Vargas C; Hanhineva K; Tornevi A; Johansson I; Koponen J; Kiviranta H; Rolandsson O; Bergdahl IA; Landberg R; Akesson A; Brunius C
Journal article: ISEE CONFERENCE ABSTRACTS. 2020;2020(1)
A common adverse outcome pathway for toxic metals inducing nephrotoxicity to aid human health risk assessment of chemical mixtures
Schillemans T; Åkesson A; Mengelers M; Luijten M
Journal article: ISEE CONFERENCE ABSTRACTS. 2020;2020(1)
Plasma metabolites associated with exposure to perfluoroalkyl substances and risk of type 2 diabetes - a nested case-control study
Schillemans T; Shi L; Donat-Vargas C; Tornevi A; Sommar J; Johansson I; Koponen J; Kiviranta H; Hanhineva K; Rolandsson O; Bergdahl I; Landberg R; Åkesson A; Brunius C
Article: METABOLITES. 2019;9(7):E133-133
Visualization and Interpretation of Multivariate Associations with Disease Risk Markers and Disease Risk-The Triplot
Schillemans T; Shi L; Liu X; Akesson A; Landberg R; Brunius C

All other publications

Review: BASIC AND CLINICAL PHARMACOLOGY AND TOXICOLOGY. 2024;134(1):141-152
Per- and polyfluoroalkyl substances and cardiometabolic diseases: A review
Schillemans T; Donat-Vargas C; Akesson A
Thesis / dissertation: 2023
Persistent environmental pollutants and risk of cardiovascular disease
Schillemans, Tessa
Conference publication: TOXICOLOGY LETTERS. 2022;368:S67
Development of quantitative adverse outcome pathways to address the effects of PFAS on cholesterol metabolism. Benchmarking with human epidemiological data and comparison with threshold values
Westerhout J; Krishnan S; Schillemans T; Akesson A; Kramer N; Louisse J; Legler J; Princen H; Stierum R
Preprint: SSRN ELECTRONIC JOURNAL.
PFAS Association with Kisspeptin and Sex Hormones in Teenagers of the HBM4EU Aligned Studies
Rodríguez-Carrillo A; Remy S; Koppen G; Wauters N; Freire C; Olivas-Martínez A; Schillemans T; Akesson A; Desalegn A; Iszatt N; Hond ED; Verheyen VJ; Fábelová L; Murinova LP; Díaz SP; Castano A; García-Lario JV; Cox B; Govarts E; Baken K; Tena-Sempere M; Olea N; Schoeters G; Fernández MF

Employments

Postdoctoral Researcher, Institute of Environmental Medicine, Karolinska Institutet, 2023-2024

Degrees and Education

Degree Of Doctor Of Philosophy, Institute of Environmental Medicine, Karolinska Institutet, 2023
Msc, Molecular Mechanisms of Disease, Radboud University Nijmegen, 2018
Bsc, Biology, Leiden University, 2015

About me

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI